ADX-47273 is a research pharmaceutical developed by Addex Therapeutics which acts as a positive allosteric modulator (PAM) selective for the metabotropic glutamate receptor subtype mGluR<sub>5</sub>. It has nootropic and antipsychotic effects in animal studies, and has been used as a lead compound to develop improved derivatives.